Tag: Antiviral Favipiravir
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.